Spring 2023 SWOG Hybrid Group Meeting
SWOG's Spring 2023 Hybrid Group Meeting will take place May 10-13 at the Hyatt Regency San Francisco and online. All session times are in Pacific Time (PT). For Group Meeting questions not answered here, you can send us a message to email@example.com.
Registration for virtual attendees only has reopened. All in person attendees should register at the onsite registration desk beginning Wednesday, May 10 at 7:00 am PT.
Virtual attendees and presenters may access call-in links on our virtual meeting webpage: https://www.swog.org/swog-spring-2023-virtual-meeting-details
SWOG strongly recommends in-person meeting attendees follow the below precautions:
- Stay up to date with COVID-19 vaccinations.
- Do not attend the meeting if you have symptoms consistent with COVID-19, and leave the meeting if you develop such symptoms.
- Wear a mask in crowded indoor settings, in consideration of those around you and our patients back home.
- Review current CDC and applicable local guidance for protecting yourself from COVID-19.
A majority of meetings will be hybrid, with virtual attendance options if you are not able or choose not to attend in-person. If SWOG determines changes to these health requirements are necessary, we will notify meeting registrants by email. We recommend you monitor CDC COVID-19 community levels.
Most Sessions Will Also Be Live-Streamed
If you are unable to travel to the San Francisco meeting, or if you cannot or choose not to comply with the vaccination recommendation, please join us online for live-streamed sessions. Remote attendees and presenters can access call links for open sessions on our virtual meeting webpage. Call-in details for invitation-only meetings will not be posted but instead will be sent out by email to all those invited.
- Meeting Booklet
- Report of Studies
- Exhibitor Information: Exhibits will be held May 11-12 from 8:00 am - 5:00 pm. Details for exhibiting can be found here.
- Pharmaceutical Partners: We look forward to your participation at the SWOG 2023 Spring Group Meeting!
Please note: SWOG has updated the registration policy to ensure we can maintain meetings of the highest caliber. Pharma partners attending in person and not specifically invited to present as part of the Group Meeting Agenda will be required to pay a per person registration fee of $250.
Please visit The Hope Foundation’s Group Meeting Registration Payment Page to make any necessary payments. Payment can be made via credit card or check. Questions can be directed to Morgan Cox at firstname.lastname@example.org // (734) 998-6887.
- Speaker/Planner Disclosures (will be available early May)
Tweeting the meeting? Please use the hashtag #swogonc.
You can reserve your hotel room at the Hyatt Regency online or by calling 415-788-1234. When calling, ask for the SWOG room block. The Group room rate is $292 plus tax. The cut-off date for making reservations is April 10. Any reservations after that time will be based on rate and space availability. To cancel or change your Hyatt reservation, call 415-788-1234.
The Hyatt is sold out of standard rooms at the group rate for some of the conference dates. If you are making a reservation, it will be at the best available rate. If your dates are not available in the SWOG room block please visit the main reservation page (http://sanfranciscoregency.hyatt.com) to view their best available rates during your stay.
If accommodations are not available at the Hyatt Regency San Francisco, some nearby hotels that you can check with are:
|Grand Hyatt San Francisco
345 Stockton Street
|Hilton Financial District
756 Kearny Street
|The Westin St Francis
335 Powell Street
165 Steuart Street
Need Special Accommodations?
If you need special arrangements or accommodations to fully participate in all Group Meeting functions, please contact the meetings manager at email@example.com after you register online.
Group Meeting Funding/Travel Support
SWOG and The Hope Foundation provide funding to support travel for member CRAs and nurses, NCORP Early-Stage Investigators, Board of Governors members, and Modality and Discipline Investigators to attend the group’s semi-annual meetings. Committee funds are also available through The Hope Foundation to help support committee efforts at the group meetings that aren't funded via the NCORP or NCTN grants.
For specific details and links to apply, please visit the Funding and Travel Support page: Group Meeting Funding/Travel Support | SWOG
Group Meeting Event Information
Special Symposium: Choosing an Omics Platform for your Clinical Trial
Thursday, May 11, 8:00-10:00 am PT
A round robin of our colleagues from industry will share concise overviews of their OMICs platforms at this Thursday morning event. They will then be available at exhibit tables in the Grand Ballroom Foyer for one-on-one questions and conversations on both Thursday and Friday.
8:00am – Welcome by Lee Ellis, MD, FASCO
- Guardant Health, Justin Odegaard, MD, PhD, Vice President of Clinical Development
- Veracyte, Ewan Gibb, PhD, Principal Scientist, Bladder Cancer Lead
- Foundation Medicine, Mia Levy, MD, PhD, Chief Medical Officer
- Exact Sciences, Christy Russell, MD, Vice President of Medical Affairs, Precision Oncology
- BostonGene, Patrick Clayton, PhD, Business Development and Aliance Manager
- Caris Life Sciences, Ari VanderWalde, MD, MPH, FACP, Vice President of Clinical Development, Precision Oncology Alliance
- Tempus, Calvin Chao, MD, Senior Vice President of Medical Affairs
- Natera, Adam ElNaggar, MD, FACOG, Medical Director, Oncology
10:00am – Closing and thank you!
Please visit the meeting exhibits to follow up and learn more.
Plenary I (Translational Medicine)
The spring meeting's Translational Medicine Plenary will take place Thursday, May 11, 3:30 - 5:00 pm PT. Speakers and topics:
- Introductory Comments
Lee M. Ellis, MD, FASCO
Vice-Chair for Translational Medicine
- The Hope Foundation Coltman Fellowship: Building a Career in Personalized Cancer Care through SWOG
Meghna S. Trivedi, MD, MS
Assistant Professor of Medicine, Herbert Irving CCC, Columbia University
- A Brief History of Time and Effort
Jerald Radich, MD
Fred Hutchinson Cancer Center
- Come Together: Collaborating with Statisticians for Productive Translational Medicine Research in SWOG
Megan Othus, PhD
Statistician, SWOG Statistics and Data Management
Plenary II (General)
SWOG's spring 2023 general plenary session will take place Friday, May 12, 12:00 - 2:00 pm PT. The plenary theme is Global Oncology Research: Transcending Borders. Presentations will be followed by a Q&A session.
- Chair’s Welcome and Update
Charles D. Blanke, MD
SWOG Group Chair
- SWOG Latin America Initiative (SLAI): Progress and Directions
Mariana Chavez MacGregor, MD, MSc
SWOG Executive Officer for International Affairs
- Partnership and Education as Components of Global Oncology Research
Julie R. Gralow, MD
Executive Vice President and Chief Medical Officer, American Society of Clinical Oncology (ASCO)
- Translating Global Health Lessons Learned in Africa to Latin America
Ophira Ginsburg, MSc, MD
Senior Advisor for Clinical Research, Center for Global Health, National Cancer Institute
- Enhancing Diversity through International Research
Angelica Nogueira-Rodrigues, MD, PhD
Professor, Universidade Federal de Minas Gerais, Brazil
CRA Clinical Trials Training Course
The Clinical Trials Training Course will be held on Wednesday, May 10, 7:20 am - 5:00 pm PT. It introduces the fundamentals of SWOG and National Cancer Institute (NCI) policies and procedures. It provides the foundation to efficiently perform responsibilities as a Clinical Research Associate. Space is limited, so sign up early!
Course Description Agenda & Handouts
Nursing Research Subcommittee
The Nursing Research Subcommittee meeting will be held on Wednesday, May 10, 10:00 - 11:45 am PT. The meeting is open to Nurse Scientists interested in advancing collaborative research within the clinical trials network as principal and co-investigators and to Nurses interested in serving as Coordinators for studies involving unique or unfamiliar assessments and/or behavioral interventions. Additionally, we are seeking to increase the representation and involvement of Advanced Practice Nurses within SWOG serving as site investigators for DCP studies. If you are interested in attending (and are not on our email distribution list), please contact Jamie Myers, Chair, at firstname.lastname@example.org.
TAKE ACTION SYMPOSIUM: Reducing Structural Barriers, Ensuring Equity in Clinical Research
Please join us for the TAKE ACTION Symposium presented by the SWOG Recruitment and Retention Committee on Wednesday, May 10, 3:00 - 5:00 pm PT. This interactive discussion will focus on reducing structural barriers. Don’t miss this opportunity to hear from subject matter experts and learn of ways to increase diversity in clinical trials. Topics include 1) Novel approaches to trial design 2) Patient stipends and 3) Improving representativeness.
Continuing education credit will be available.
The Site Operations meeting is scheduled for Wednesday, May 10, 5:30 - 7:30 pm PT.
SWOG values the Research Team Members who work with Investigators to make cancer research happen. It "takes a village" to lead research sites and make it possible for participants to enroll on trials. This special perspective is the focus of Site Operations, a subcommittee of the Oncology Research Professionals (ORP) Committee. A variety of practical topics will be discussed, including:
- SWOG statistical and operations updates
- NCI changes and new information
- SWOG quality assurance topics and questions
This meeting is open to everyone and provides an opportunity to hear updates and ask questions. Please join us!
Jeri & Noboru Oishi Symposium
The Jeri and Noboru Oishi Symposium will be held on Thursday, May 11, 8:00 - 11:00 am PT (check-in begins at 7:30). Join us to revisit the “Land of Oz”. Traveling along The Yellow Brick Road, we’ll trace the journey of an NCI SWOG protocol as it weaves along the path from beginning to end. Come along on the journey and learn how dreams of a protocol become a reality, how Tin Men and Scarecrows are the friends who help along the way getting the complex work done, how to avoid “Wicked Witch of the West” protocol challenges, and the joy of finding the “Emerald City” where trials arrive at enrollment, sites enroll successfully, and broomsticks from SAEs and queries are vanquished. On the journey, you’ll be guided by many “Wizards” who will show you the “Magical Oz”, a clinical trial survivor who “made the journey”, and show you the how a large number of yellow bricks become a path to a final successful protocol.
Starring roles by SWOG Stats & Ops, the NCI, Site Panelists, Dr. David Zhen, along cameo appearances by Auntie Em and Glinda the Good Witch of the North. Don’t miss this all-star cast in a unique and never to be repeated “Oishi Show-Stopper”!
Oncology Research Professionals Open Forum
The ORP Open Forum is set for Thursday, May 11, 1:00 - 2:30 pm PT. Round table discussions are back! Please join us in-person to discuss topics in a small group setting. Rotate between four 20-minute sessions of your choice to learn more about conducting SWOG trials, mitigating challenges, and implementing strategies with your facilitator and tablemates.
Please note we encourage in-person attendance as there will be no remote meeting links for this forum. Although recordings of the round table discussions will not be made, we will post handouts and facilitator contact details for each table topic to the SWOG website after the Group Meeting.
This meeting is open to everyone and provides an opportunity to hear updates and ask questions. Please join us!
Nicholas J. Vogelzang, MD, GU Symposium: Microbiome as a New Frontier in SWOG Clinical Trials
This spring's Nicholas J. Vogelzang, MD, Symposium, to be held Friday, May 12, from 8:30 - 11:30 am PT, will address the topic of microbiome as a new frontier in SWOG clinical trials.
Honoring the many valuable contributions Dr. Vogelzang has made in support of his colleagues and patients throughout his career within SWOG’s research network, Vogelzang symposia are held at SWOG group meetings to provide members with the latest and best resources for extending and improving the lives of those impacted by genitourinary cancers.
Vogelzang Symposium Speakers include:
- Introduction: Sumanta K. Pal, MD, FASCO & Michael A. Liss, MD, PhD
- Keynote speaker: Bertrand Routy, MD, Director of Immunology & Oncomicrobiome, University of Montreal
- Laura Bukavina, MD, Fox Chase Cancer Center
- Nazli Dizman, MD, Yale University
- Nadim Ajami, PhD, MD Anderson Cancer Center
- Mike Wu, PhD, Fred Hutchinson Cancer Center
This will be an informative symposium you won't want to miss!